The largest database of trusted experimental protocols

Dmem f12 ham s medium

Manufactured by Merck Group
Sourced in Germany

DMEM/F12 Ham's medium is a cell culture medium formulation used for the maintenance and growth of various types of cells in vitro. It is a mixture of essential nutrients, vitamins, and other components required for cell proliferation and survival. The medium is designed to support the optimal growth and maintenance of a wide range of cell lines, including both adherent and suspension cultures.

Automatically generated - may contain errors

5 protocols using dmem f12 ham s medium

1

Orthotopic HGSOC Mouse Models

Check if the same lab product or an alternative is used in the 5 most similar protocols
HGSOC mouse orthotopic cell lines; 30200 and 60577 were derived from serous ovarian cancer GEMMs 15 (link) and engineered to express Trp53−/−, Brca1−/− and Rb inactivation. Following intraperitoneal cell injection, they form extensive disease in the omentum and also metastasize to the spleenoportal fat, lesser omentum and mesentery. The two models vary in their average survival time with 20 weeks (30200) and 6 weeks (60577). HGS2 cell line was derived from a Pax-8-cre inducible GEMM driving inactivation of Trp53, Brca2 and Pten in the fallopian tube epithelium. This model is syngeneic with C57 BL/6J background and upon intraperitoneal cell injection form extensive disease in the omentum and peritoneum similar to the other models by 12-14 weeks.
These orthotopic transplantable lines were grown in DMEM/F12 Ham’s medium (Sigma-Aldrich) constituted with 2% fetal bovine serum (Gibco Invitrogen) 100 units/ml penicillin G sodium, and 100 μg/ml streptomycin sulfate (Invitrogen). The medium was also supplemented with 5ml of 100x Insulin/Transferrin/Selenium (Invitrogen), 5ml of 50ug/ml of Hydrocortisone (Sigma-Aldrich), 5ml of 100x anti-anti (Gibco) and 500ul of 10ug/ml murine epidermal growth factor. Cells were trypsinized with 0.25% trypsin-EDTA (Sigma Aldrich) and split 1:4.
+ Open protocol
+ Expand
2

AAV Production via Calcium Phosphate Transfection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transfection was performed using a calcium phosphate co-precipitation method based on previous reports (Dudek et al., 1998 (link); Okada, 2013 ) with slight modifications. In brief, 2 days before transfection, 3 × 106 each of AAV-293 cells was reseeded in four T-150 flasks and cultured to 60–70% confluency in 18 ml of culture medium. One to four hours before transfection, a half volume of the culture medium was replaced with a fresh growth medium. Subsequently, 60 μg each of the plasmid (expression vector, Rep/Cap vector, and pHelper) was mixed well with 6 ml of 0.3 M CaCl2 solution and then finally combined with an equal amount of 2 × HBS. Three ml each of the final solution was applied to each culture flask. Following a 4-h incubation in a 5% CO2 incubator, the supernatant was replaced with DMEM/F-12 Ham’s medium (Sigma–Aldrich) containing 2% FBS, 50 mg/ml of streptomycin, and 2mM GlutaMAX I (Thermo Fisher Scientific) and incubated at 37°C in a 10% CO2 humidified incubator. Cells and culture medium were harvested 2–3 days after transfection, and AAV was purified using the AAV Purification ViraKit (ViraPur LLC) following the manufacturer’s manual. The details of the AAV preparation protocol are available upon request. The virus concentration was quantified using AAVpro® Titration Kit (Takara Bio) and used at a concentration of ~1.5 × 1013 vg/ml.
+ Open protocol
+ Expand
3

Quantifying Cell Migration Dynamics

Check if the same lab product or an alternative is used in the 5 most similar protocols
siRNAs from the first screening, NT siRNA, or anti-Pxn siRNA plus the pVenus-N1 vector were introduced into NBT-L2b cells by the conventional transfection method described above. After 38 h, siRNA-transfected cells (3 × 104 cells) were diluted in 1 ml of DMEM/F12 Ham’s medium (Sigma), supplemented with 10% fetal bovine serum and a mixture of antibiotics, and seeded in wells of a non-treated 24-well microplate (Asahi Glass., Ltd, Tokyo, Japan) that had been coated with a 0.001% solution (w/v) of type I collagen (Research Institute for Functional Peptides, Yamagata, Japan). After a 3-h incubation, the medium was replaced with 1 ml of fresh DMEM/F12 Ham’s medium. The microplate was placed in a Programmable Cellular Image Tracer and incubated for at least 3 h. Fluorescence and phase-contrast snapshot images were captured and phase-contrast time-lapse images were recorded for 6 h at 5-min intervals with the Image Tracer, and analyzed with the ImageJ software. The migration speeds of cells that had been transfected with NT siRNA and the test siRNAs were compared by the Mann-Whitney U-test (statistical significance recognized at P < 0.05, NT versus each siRNA).
+ Open protocol
+ Expand
4

Ligamentocyte Isolation and Cultivation

Check if the same lab product or an alternative is used in the 5 most similar protocols
LACL-derived ligamentocytes were harvested from six adult males, healthy 12-month-old ACLs of New Zealand Rabbits, obtained from the regional slaughterhouse. The explanted LACLs were split into 2-mm2 pieces and were cultivated in T25 culture flasks in growth medium (Dulbecco's modified Eagle’s medium [DMEM]/Ham’s F12 medium [1:1, Merck KGaA, Darmstadt, Germany] supplemented with 10% fetal bovine serum [FBS, Merck KGaA], 1% penicillin/streptomycin solution [Merck KGaA], 25 μg/ml ascorbic acid [Sigma-Aldrich, Munich, Germany], 2.5 μg/ml amphotericin B [Merck KGaA], MEM amino acid solution [Sigma-Aldrich]). After 7–10 days, ligamentocytes emigrated and were expanded using 0.05% trypsin/0.02% ethylenediaminetetraacetic acid (EDTA) for the subsequent experiments.
+ Open protocol
+ Expand
5

Isolation and Culture of Rabbit ACL Fibroblasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
LACL-derived fibroblasts were isolated from 7 female, healthy ACLs of New Zealand Rabbits (approximate 12 months) derived from the abattoir. Explanted LACLs were sliced into 2 mm2 pieces and placed into a T25 culture flask with growth medium for several weeks (Dulbecco’s Modified Eagle´s Medium (DMEM)/Ham’s F12 medium (1:1, Merck KGaA, Darmstadt, Germany) supplemented with 10% fetal bovine serum (FBS, Merck KGaA), 1% penicillin/streptomycin solution (Merck KGaA), 25 μg/mL ascorbic acid (Sigma-Aldrich, Munich, Germany), 2.5 μg/mL amphotericin B (Merck KGaA), MEM amino acid solution (Sigma-Aldrich). After 7–10 days, emigrating cells could be harvested using 0.05% trypsin/0.02% EDTA treatment and be further expanded.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!